Terence Flynn

Q: How accurate are Terence Flynn's stock ratings?

About 56% of Terence's ratings were profitable over a one-year hold, with an average return of +3.4% per rating, measured by 13Foresight from historical prices.

Q: How is Terence ranked?

Terence Flynn is ranked #875 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Morgan Stanley

Wall Street Analyst

★★★★☆

#875

on 13Foresight · ranked by our own returns

55%

Success Rate

+3.2%

Average Return

79 of 144 calls profitable · +1.0% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 55% of Terence Flynn's ratings turned a profit when each position was held for 1 year — averaging +3.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

126 Buy 103 Hold 14 Sell

Terence's Stock Coverage 40 ratings · 2026-11-04

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
MRK Merck & Company	Oct 30, 2026	BUY	Strong Buy -3.5% avg upside 44 analysts	$174.00 16.45% Upside	-0.8%	·
GILD Gilead Sciences	Oct 30, 2026	BUY	Strong Buy -27.3% avg upside 66 analysts	$183.00 7.24% Upside	-0.2%	·
LLY Eli Lilly & Co	Oct 30, 2026	BUY	Strong Buy -16.7% avg upside 50 analysts	$1596.00 12.69% Upside	-0.5%	·
BMY Bristol-Myers Squibb	Oct 30, 2026	SELL	Buy -2.2% avg upside 42 analysts	$40.00 36.02% Downside	-0.9%	·
BIIB Biogen	Oct 29, 2026	HOLD	Strong Buy +6.6% avg upside 53 analysts	$231.00 8.88% Downside	+1.9%	·
BNTX BioNTech SE	Oct 26, 2026	BUY	Strong Buy +48.9% avg upside 28 analysts	$114.00 29.39% Upside	+4.4%	·
ABBV AbbVie	Oct 22, 2026	BUY	Strong Buy -14.5% avg upside 47 analysts	$310.00 5.18% Upside	+3.3%	·
RCUS Arcus Biosciences	Oct 20, 2026	HOLD	Strong Buy +98.9% avg upside 22 analysts	$23.00 26.46% Upside	-24.8%	·
NRIX Nurix Therapeutics	Oct 15, 2026	BUY	Strong Buy +22.5% avg upside 28 analysts	$38.00 41.87% Upside	-36.1%	·
JNJ Johnson & Johnson	Oct 15, 2026	BUY	Strong Buy -9.1% avg upside 40 analysts	$292.00 6.98% Upside	+8.8%	·
AMGN Amgen	Oct 07, 2026	HOLD	Buy -29.9% avg upside 57 analysts	$359.00 23.06% Downside	+13.2%	·
RPRX Royalty Pharma	Oct 07, 2026	BUY	Strong Buy -12.2% avg upside 15 analysts	$67.00 0.19% Downside	+19.0%	·
MRNA Moderna	Oct 07, 2026	HOLD	Hold -48.5% avg upside 38 analysts	$95.00 57.17% Downside	+31.5%	·
VRTX Vertex Pharmaceuticals	Oct 07, 2026	BUY	Strong Buy -20.5% avg upside 62 analysts	$665.00 18.94% Upside	+9.4%	·
UTHR United Therapeutics	Oct 07, 2026	HOLD	Buy -22.7% avg upside 27 analysts	$566.00 5.45% Downside	+10.3%	·
REGN Regeneron	Oct 07, 2026	HOLD	Strong Buy -12.1% avg upside 60 analysts	$779.00 16.12% Downside	+29.5%	·
PFE Pfizer	Oct 07, 2026	HOLD	Buy +9.2% avg upside 46 analysts	$28.00 8.24% Downside	+9.5%	·
ALMS Alumis Inc.	Sep 02, 2026	BUY	Strong Buy +361.9% avg upside 11 analysts	$29.00 330.90% Upside	-36.7%	·
LEGN Legend Biotech	Aug 12, 2026	BUY	Strong Buy +182.2% avg upside 27 analysts	$48.00 121.90% Upside	+10.3%	·
BHVN Biohaven Ltd.	Aug 12, 2026	BUY	Buy +51.3% avg upside 25 analysts	$19.00 23.22% Upside	+6.4%	·
ARVN Arvinas Holding Company	Aug 10, 2026	HOLD	Buy +258.0% avg upside 28 analysts	$10.00 27.32% Upside	-17.5%	·
GPCR Structure Therapeutics, Inc. Sponsored ADR	Aug 10, 2026	BUY	Strong Buy +373.2% avg upside 17 analysts	$126.00 476.18% Upside	-62.0%	·
PRME Prime Medicine, Inc.	Aug 10, 2026	HOLD	Strong Buy +101.7% avg upside 18 analysts	—	-1.7%	·
NTLA Intellia Therapeutics	Aug 10, 2026	HOLD	Buy +187.2% avg upside 39 analysts	$15.00 20.21% Upside	+2.4%	·
OGN Organon	Apr 10, 2026	HOLD	Sell +7.4% avg upside 9 analysts	$9.00 35.06% Downside	+57.2%	·
CRSP Crispr Therapeutics AG	Feb 17, 2026	SELL	Buy +45.6% avg upside 41 analysts	$33.00 35.78% Downside	+0.2%	·
CCCC C4 Therapeutics	Sep 21, 2025	HOLD	Strong Buy +405.9% avg upside 21 analysts	—	+26.4%	·
EDIT Editas Medicine	Dec 13, 2024	HOLD	Buy +398.5% avg upside 33 analysts	—	+75.7%	·
ALKS Alkermes	Jun 01, 2021	SELL	Strong Buy -3.4% avg upside 34 analysts	$16.00 64.63% Downside	-29.5%	·
CTMX CytomX Therapeutics	Aug 10, 2020	HOLD	Strong Buy +361.2% avg upside 21 analysts	$12.00 412.89% Upside	-35.6%	·
DE:MRK Merck KGaA	Aug 03, 2020	BUY	Buy -7.2% avg upside 34 analysts	$93.70 38.05% Downside	+61.6%	·
TSE:BHC Bausch Health Companies	Dec 02, 2019	HOLD	Buy +386.9% avg upside 30 analysts	$41.93 265.59% Upside	-35.1%	·
KLDO Kaleido Biosciences	Mar 25, 2019	BUY	Buy +13249900.0% avg upside 5 analysts	$20.00 19999899.92% Upside	·	·
DNTH Dianthus Therapeutics	Mar 25, 2019	HOLD	Strong Buy +23.4% avg upside 32 analysts	$16.00 80.59% Downside	-67.9%	·
ALNY Alnylam Pharma	Aug 13, 2018	BUY	Strong Buy +76.3% avg upside 53 analysts	$155.00 6.16% Downside	-12.0%	·
KNSA Kiniksa Pharmaceuticals	Jun 18, 2018	HOLD	Strong Buy -11.0% avg upside 12 analysts	$22.00 76.11% Downside	-22.1%	·
KYNB Kyntra Bio	Jul 21, 2017	HOLD	Buy +615.8% avg upside 17 analysts	$31.00 578.25% Upside	·	·
AGIO Agios Pharma	Jun 13, 2016	HOLD	Strong Buy +99.0% avg upside 30 analysts	$46.00 50.64% Upside	-2.4%	·
ATRA Atara Biotherapeutics	Nov 18, 2015	HOLD	Buy +125.8% avg upside 18 analysts	$38.00 374.31% Upside	·	·
MCRB Seres Therapeutics	Jul 21, 2015	HOLD	Buy +836.2% avg upside 11 analysts	$36.00 1933.95% Upside	·	·

🔒 35 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Terence Flynn — Frequently Asked Questions

How accurate are Terence Flynn's stock ratings?

Based on the calls 13Foresight could measure, about 56% of Terence's ratings were profitable over a one-year hold, with an average return of +3.4% per rating, or +1.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Terence ranked on 13Foresight?

Terence Flynn is currently ranked #875 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Terence cover?

Terence most recently has ratings on MRK, GILD, LLY, BMY, BIIB, BNTX, ABBV, RCUS, NRIX, JNJ, AMGN, RPRX and 28 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Terence Flynn

Rating Distribution

Welcome to 13Foresight!